New arthritis drug enters human testing after surprising early results
Disease control
Not yet recruiting
This early-stage study is testing a new drug called SR-878 in people with rheumatoid arthritis to see if it's safe and to find the right dose for future research. The drug works differently than current treatments by targeting a protein involved in inflammation. Researchers will …
Phase: PHASE1 • Sponsor: SciRhom GmbH • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC